Avarol, a cytostatically active compound from the marine sponge Dysidea avara

Area of Science:

• Marine natural products chemistry
• Cell biology
• Pharmacology

Background:

• Marine sponges are a rich source of bioactive compounds.
• Dysidea avara produces unique sesquiterpenoid hydroquinones.
• Avarol is a significant metabolic product of D. avara.

Purpose of the Study:

• To isolate, purify, and identify a key metabolite from Dysidea avara.
• To investigate the cytostatic activity and mechanism of action of avarol.
• To evaluate the effect of avarol on cell growth and synthesis pathways.

Main Methods:

• Isolation and purification of avarol using spectroscopic techniques (NMR, i.r.).
• In vitro cytostatic assays using the L5178y mouse lymphoma cell system.
• Incorporation studies of DNA, RNA, protein, and glycoprotein precursors.
• Autoradiographical experiments to elucidate mechanism of action.

Main Results:

• Avarol was identified as a sesquiterpenoid hydroquinone with significant cytostatic effects.
• Avarol inhibited cell growth by 50% at 0.9 microM in mouse lymphoma cells.
• The compound interfered with mitosis, specifically preventing telophase.
• Increased incorporation of precursors for DNA, RNA, protein, and glycoprotein synthesis was observed.
• Avarol diacetate demonstrated comparable cytostatic activity to avarol.

Conclusions:

• Avarol's cytostatic activity is linked to mitotic interference and altered precursor uptake.
• Changes in intracellular pools or cell membrane permeability may mediate avarol's effects.
• Avarol represents a promising lead compound for anticancer drug development.